{
    "2018-12-02": [
        [
            {
                "time": "2018-03-15",
                "original_text": "IMBRUVICAÂ® (ibrutinib) Data in Chronic Lymphocytic Leukemia (CLL) Show up to Seven Years of Progression-free Survival (PFS) in 80 Percent of Previously Untreated Patients, the Longest Follow-up for a Bruton's Tyrosine Kinase Inhibitor to Date",
                "features": {
                    "keywords": [
                        "IMBRUVICA",
                        "ibrutinib",
                        "Chronic Lymphocytic Leukemia",
                        "Progression-free Survival",
                        "Seven Years",
                        "Previously Untreated Patients"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-20",
                "original_text": "Why Is AbbVie (ABBV) Up 17.5% Since Last Earnings Report?",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "ABBV",
                        "Earnings Report",
                        "Up 17.5%"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}